PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Mebrofenin→

Mebrofenin PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
78266-06-5
Molecular formula
C15H19BrN2O5
Molecular weight
387.23 g/mol
Drug class
Diagnostic radiopharmaceuticalhepatobiliary iminodiacetic-acid (IDA) imaging agent
Mechanism of action
When labelled with technetium-99m, mebrofenin is rapidly cleared from the circulation by hepatic uptake and excreted into bile. Its gamma emissions allow visualisation of hepatobiliary transit by scintigraphy or SPECT; it has no pharmacological effect at diagnostic doses.
Indications / reported uses
  • Hepatobiliary scintigraphy to assess liver uptake, biliary excretion and gallbladder/biliary tract function, according to the radiopharmaceutical product protocol.

Sources: https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-mebrofenin · https://eanm.org/wp-content/uploads/2024/06/EANM_2023_TechGuide.pdf

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Mebrofenin PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Mebrofenin Permitted Daily Exposure (PDE) report (the Mebrofenin PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Mebrofenin Occupational Exposure Limit (OEL) report (the Mebrofenin OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.